Fundai

Farabi Pharmaceutical Company (DFARA) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DFARA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations7,260,686-557,5211,422,512928,6612,171,636986,832
Cash payments for income tax-1,116,267-88,000-367,470-200,519-51,214-69,526
Net cash inflow (outflow) from operating activities6,144,419-645,5211,055,042728,1422,120,422917,306
Cash payments for purchase of property, plant and equipment-75,883-38,496-67,955-107,963-9,128-32,929
Cash payments for purchase of intangible assets-56,250-7,332-8,030-374-5,507-975
Cash receipts from interest on other investments3,8334,1045,4978,9286,9973,198
Net cash inflow (outflow) from investing activities-128,300-41,724119,711-99,409242,362-69,298
Net cash inflow (outflow) before financing activities6,016,119-687,2451,174,753628,7332,362,784848,008
Cash receipts from facilities5,255,9144,274,2201,985,0002,731,0002,696,7564,816,681
Cash payments for principal of loans-5,244,810-1,926,425-3,553,693-2,518,310-4,438,183-3,830,543
Cash payments for interest on loans-732,400-790,038-409,683-346,414-542,603-273,108
Cash payments for dividends-5,227,484-906,736-319,123-753,191-261,837-1,590,458
Net cash inflow (outflow) from financing activities-5,948,780651,021-2,297,499-886,915-2,545,867-921,778
Net increase (decrease) in cash67,339-36,224-1,122,746-258,182-183,083-73,770
Cash balance at beginning of year899,795479,8331,389,9541,765,506586,777454,985
Effect of changes in exchange rates66,87325,06021,5381,655-1,887249
Cash balance at end of year1,034,007468,669288,7461,508,979401,807381,464

Reporting periods

77 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.